Log in to save to my catalogue

Baricitinib for the Treatment of Alopecia Areata

Baricitinib for the Treatment of Alopecia Areata

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2814815868

Baricitinib for the Treatment of Alopecia Areata

About this item

Full title

Baricitinib for the Treatment of Alopecia Areata

Publisher

New Zealand: Springer Nature B.V

Journal title

Drugs (New York, N.Y.), 2023-06, Vol.83 (9), p.761-770

Language

English

Formats

Publication information

Publisher

New Zealand: Springer Nature B.V

More information

Scope and Contents

Contents

Alopecia areata (AA) is a relapsing, chronic, immune-mediated disease characterized by nonscarring, inflammatory hair loss that can affect any hair-bearing site. AA clinical presentation is heterogeneous. Its pathogenesis involves immune and genetic factors and several pro-inflammatory cytokines involved in AA pathogenesis, including interleukin-15...

Alternative Titles

Full title

Baricitinib for the Treatment of Alopecia Areata

Authors, Artists and Contributors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2814815868

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2814815868

Other Identifiers

ISSN

0012-6667

E-ISSN

1179-1950

DOI

10.1007/s40265-023-01873-w

How to access this item